Content - Home
The Swiss Cancer Bulletin 01/2017 on the subject of “Molecular Biology and Pathology” has been published
The first issue of the Swiss Cancer Bulletin in 2017 is concerned with molecular biology and pathology.
SAKK has activated a new trial for patients with advanced oesophageal cancer.
Dr. Benjamin Weixler was awarded the 2016 SAKK / Dr. Paul Janssen Fellowship. In an interim report, he shares his experiences of the...
The core task of SAKK is to conduct clinical cancer research (see our research strategy). Researchers in the SAKK network regularly exchange scientific knowledge and findings. Study proposals are initiated and discussed at these expert meetings, then developed further before presented to the board for assessment. We encourage interested researchers who want to engage and collaborate with us to submit their proposals: Project submission